Developer docs
API playgroundTry for free, no card

Search company profiles

SCVC

Full company profile

uuid00005tu

Namestring
SCVC
Legal namestring
Science Creates Ventures LLP
Websiteurl
scvc.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

SCVC (Science Creates Ventures LLP) is an early-stage venture capital firm headquartered in Bristol, United Kingdom, founded in 2020 by Harry Destecroix as the investment arm of the broader Science Creates ecosystem. The firm specialises in UK-based Deep Tech startups spanning biotech, quantum, AI, synthetic biology, and advanced materials, deploying capital from pre-seed through Series A. SCVC applies a proprietary "technology-product fit" model to guide portfolio companies through technical and commercial de-risking, differentiating from generalist VCs by focusing exclusively on hard-technology bets with long development cycles. The firm's leadership team comprises exited founders and technical specialists: Destecroix previously led Ziylo to a 2018 acquisition worth up to $800m; General Partner John Williams co-founded and served as CTO of Kudan Inc, which exceeded a $1bn market cap on its Tokyo Stock Exchange IPO; and Principal Laura Davies is a biochemist with industry experience at Adaptimmune and BBSRC-UKRI.

The firm operates within a vertically integrated ecosystem that includes three physical incubators (Old Market, St Philips, OMX), an Accelerate training platform, and the Science Creates Outreach STEM education initiative, providing portfolio companies with laboratory infrastructure and operational support beyond capital. SCVC has raised £53m+ in total capital, deployed £25m+ across 18 portfolio companies, and is regulated by the UK Financial Conduct Authority (FRN:1041971). Revenue is generated through standard venture capital mechanics — management fees on committed capital and carried interest from exits — with demonstrated liquidity potential from founder Destecroix's prior Ziylo outcome and GP Williams's Kudan exit.

Deal sourcing is anchored in founder networks, university spinout ecosystems (notably University of Bristol and University of Cambridge), and the Science Creates incubator pipeline, with recent co-investments alongside NATO Innovation Fund, Earlybird Venture Capital, Deep Science Ventures, and Cambridge Enterprise VC. Portfolio highlights include Portal Biotech ($35m Series A, 2025), Zero Point Motion (£4m seed, 2025), Houdini Bio (€1.7m pre-seed, 2026), and Scarlet Therapeutics (£3.2m seed, 2026).

Short descriptiontext

SCVC is a Bristol-based early-stage Deep Tech venture capital firm investing in UK startups from pre-seed to Series A across biotech, quantum, AI, and advanced materials, embedded within the Science Creates incubator ecosystem.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBristol, United Kingdom
HQ citystring
Bristol
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
deep tech venture capital, early-stage tech investing, science startup funding, technology transfer investment, pre-seed to Series A capital
Industry3 codes
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
SECONDARYFSANAHAC
Corporate Venture Studios & Incubators (Build/launch ventures)
SECONDARYFSANAHAL
Corporate Deep Tech / R&D Commercialization CVC
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Open-End Investment Funds525910
SIC code1 code
  • Investment Advice6282
Product category
Early-Stage Venture Capital (Deep Tech)
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns
TypeLicensing Royalties
Description

SCVC generates returns through equity investments in early-stage Deep Tech companies. The firm takes equity stakes in portfolio companies and realizes returns through exits (acquisitions, IPOs). Typical VC fund structure with management fees and carried interest.

sciencecreates.co.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SCVC provides early-stage venture capital investment (pre-seed to Series A) into UK-based Deep Tech startups across biotech, quantum, AI, synthetic biology, and advanced materials. The firm applies a proprietary 'technology-product fit' model to guide founders through technical and commercial de-risking, complemented by access to the Science Creates incubator ecosystem, training platform, and development services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Ziylo acquisition for up to $800m in 2018
+2 more records
Product overview1 text field

SCVC (Science Creates Ventures) operates as an award-winning Deep Tech VC firm offering a comprehensive ecosystem for early-stage UK companies. The core offering is venture capital investment from pre-seed to series A through SCVC, complemented by physical infrastructure via Science Creates Incubators (Old Market, St Philips, OMX), the Platform (Accelerate training engine and Partnerships program), Development Services for laboratory and R&D facilities, and Science Creates Outreach for STEM education. The ecosystem applies a 'technology-product fit' model to guide Deep Tech startups through technical and commercial de-risking, focusing on sectors including biotech, quantum, AI, synthetic biology, and advanced materials.

Product and service3 records
1SCVC Venture Capital Investment (Pre-seed to Series A)
CategoryEarly-Stage Venture Capital Investment
Description

Early-stage equity capital (pre-seed to Series A) for UK Deep Tech founders developing breakthrough technologies in AI, quantum, synthetic biology, biotech, and advanced materials. SCVC applies a proprietary 'technology-product fit' model to guide teams through technical and commercial de-risking, and portfolio companies gain access to the Science Creates ecosystem including incubators, training, and lab infrastructure.

2Science Creates Incubators (Old Market, St Philips, OMX)
CategoryLaboratory Incubator Space
Description

Specialised Deep Tech incubator spaces providing wet lab and engineering lab facilities for science and engineering startups at multiple Bristol locations (Old Market, St Philips, OMX). Tenants gain access to a Deep Tech community and the broader Science Creates ecosystem.

3Development Services (Laboratory & R&D Facility Design)
CategoryLaboratory Development Services
Description

End-to-end design and delivery services for laboratory and R&D facilities, providing Deep Tech companies and research organisations with purpose-built infrastructure.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Cambridge Enterprise Ventures
TypeDirect peer
Description

University-linked seed and early-stage investor commercialising University of Cambridge deep tech research. Highly comparable to SCVC in stage, sector focus (biotech, quantum, advanced materials), and UK geography, and has appeared as a SCVC co-investor (e.g., Houdini Bio).

TypeDirect peer
Description

VC firm spun out of Oxford University investing in deep tech and life sciences from university IP. Closely comparable to SCVC in mission (commercialising UK academic deep tech), stage focus, and sector mix.

TypeBroad incumbent
Description

Largest UK-listed IP commercialisation company backing deep tech and life science spinouts from leading universities. Broader and more established than SCVC, but directly comparable in thesis of monetising UK academic deep tech at early stage.

TypeDirect peer
Description

Early-stage investor focused on the Cambridge deep tech and life sciences cluster. Closely comparable sector mix (biotech, quantum, AI) and stage, making it a natural UK peer to SCVC.

TypeDirect peer
Description

UK-based early-stage investor specialising in university spinouts and deep tech from UK research institutions. Directly comparable to SCVC in thesis, stage (pre-seed to Series A), and customer base (technical founders).

TypeBroad incumbent
Description

One of the largest UK VCs with a dedicated deep tech vertical alongside broader fintech/healthtech investing. More diversified and at larger check sizes, but operates in overlapping UK early-stage deep tech deal flow.

TypeDirect peer
Description

Venture builder creating and funding science companies from first principles. Has co-invested with SCVC (e.g., Houdini Bio), and shares a deep tech, science-first thesis with overlapping UK founder pool.

TypeDirect peer
Description

UK pre-seed and seed investor with meaningful exposure to deep tech and science-led founders. Comparable to SCVC in stage focus and UK orientation, though somewhat broader in sector mandate.

TypeBroad incumbent
Description

Prominent UK seed investor with a founder-led approach. While more software/internet biased, it competes with SCVC for top UK technical founders at pre-seed and seed stages.

TypeRegional player
Description

European deep tech and biotech-focused early-stage investor. Comparable thesis on deep tech/longevity, though primarily Continental European in focus versus SCVC's UK-centric mandate.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers17 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment24 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SCVC

Early-Stage Venture Capital (Deep Tech)scvc.com

SCVC is a Bristol-based early-stage Deep Tech venture capital firm investing in UK startups from pre-seed to Series A across biotech, quantum, AI, and advanced materials, embedded within the Science Creates incubator ecosystem.

What SCVC does

SCVC (Science Creates Ventures LLP) is an early-stage venture capital firm headquartered in Bristol, United Kingdom, founded in 2020 by Harry Destecroix as the investment arm of the broader Science Creates ecosystem. The firm specialises in UK-based Deep Tech startups spanning biotech, quantum, AI, synthetic biology, and advanced materials, deploying capital from pre-seed through Series A. SCVC applies a proprietary "technology-product fit" model to guide portfolio companies through technical and commercial de-risking, differentiating from generalist VCs by focusing exclusively on hard-technology bets with long development cycles. The firm's leadership team comprises exited founders and technical specialists: Destecroix previously led Ziylo to a 2018 acquisition worth up to $800m; General Partner John Williams co-founded and served as CTO of Kudan Inc, which exceeded a $1bn market cap on its Tokyo Stock Exchange IPO; and Principal Laura Davies is a biochemist with industry experience at Adaptimmune and BBSRC-UKRI.

The firm operates within a vertically integrated ecosystem that includes three physical incubators (Old Market, St Philips, OMX), an Accelerate training platform, and the Science Creates Outreach STEM education initiative, providing portfolio companies with laboratory infrastructure and operational support beyond capital. SCVC has raised £53m+ in total capital, deployed £25m+ across 18 portfolio companies, and is regulated by the UK Financial Conduct Authority (FRN:1041971). Revenue is generated through standard venture capital mechanics — management fees on committed capital and carried interest from exits — with demonstrated liquidity potential from founder Destecroix's prior Ziylo outcome and GP Williams's Kudan exit.

Deal sourcing is anchored in founder networks, university spinout ecosystems (notably University of Bristol and University of Cambridge), and the Science Creates incubator pipeline, with recent co-investments alongside NATO Innovation Fund, Earlybird Venture Capital, Deep Science Ventures, and Cambridge Enterprise VC. Portfolio highlights include Portal Biotech ($35m Series A, 2025), Zero Point Motion (£4m seed, 2025), Houdini Bio (€1.7m pre-seed, 2026), and Scarlet Therapeutics (£3.2m seed, 2026).

SCVC firmographics

Firmographics
Name
SCVC
Legal name
Science Creates Ventures LLP
Website
https://scvc.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
SCVC is a Bristol-based early-stage Deep Tech venture capital firm investing in UK startups from pre-seed to Series A across biotech, quantum, AI, and advanced materials, embedded within the Science Creates incubator ecosystem.
Ownership category
akta.pro rank

SCVC industry classification

Industry
Product category
Early-Stage Venture Capital (Deep Tech)
NAICS
Portfolio Management and Investment Advice (523940), Open-End Investment Funds (525910)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
SECONDARYFSANAHAC
Corporate Venture Studios & Incubators (Build/launch ventures)
SECONDARYFSANAHAL
Corporate Deep Tech / R&D Commercialization CVC

Keywords

  • Deep tech venture capital
  • Early-stage tech investing
  • Science startup funding
  • Technology transfer investment
  • Pre-seed to Series A capital

Where SCVC is headquartered

Location

Headquarters

HQ city
Bristol
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

SCVC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Venture Capital Returns: SCVC generates returns through equity investments in early-stage Deep Tech companies. The firm takes equity stakes in portfolio companies and realizes returns through exits (acquisitions, IPOs). Typical VC fund structure with management fees and carried interest.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

SCVC product offering

Product offering

Core offering

SCVC provides early-stage venture capital investment (pre-seed to Series A) into UK-based Deep Tech startups across biotech, quantum, AI, synthetic biology, and advanced materials. The firm applies a proprietary 'technology-product fit' model to guide founders through technical and commercial de-risking, complemented by access to the Science Creates incubator ecosystem, training platform, and development services.

Product overview

SCVC (Science Creates Ventures) operates as an award-winning Deep Tech VC firm offering a comprehensive ecosystem for early-stage UK companies. The core offering is venture capital investment from pre-seed to series A through SCVC, complemented by physical infrastructure via Science Creates Incubators (Old Market, St Philips, OMX), the Platform (Accelerate training engine and Partnerships program), Development Services for laboratory and R&D facilities, and Science Creates Outreach for STEM education. The ecosystem applies a 'technology-product fit' model to guide Deep Tech startups through technical and commercial de-risking, focusing on sectors including biotech, quantum, AI, synthetic biology, and advanced materials.

Differentiator

Problem solved

Functional benefit

Products and services

  • SCVC Venture Capital Investment (Pre-seed to Series A) Early-stage equity capital (pre-seed to Series A) for UK Deep Tech founders developing breakthrough technologies in AI, quantum, synthetic biology, biotech, and advanced materials. SCVC applies a proprietary 'technology-product fit' model to guide teams through technical and commercial de-risking, and portfolio companies gain access to the Science Creates ecosystem including incubators, training, and lab infrastructure.
  • Science Creates Incubators (Old Market, St Philips, OMX) Specialised Deep Tech incubator spaces providing wet lab and engineering lab facilities for science and engineering startups at multiple Bristol locations (Old Market, St Philips, OMX). Tenants gain access to a Deep Tech community and the broader Science Creates ecosystem.
  • Development Services (Laboratory & R&D Facility Design) End-to-end design and delivery services for laboratory and R&D facilities, providing Deep Tech companies and research organisations with purpose-built infrastructure.

Quantifiable outcome

  • Ziylo acquisition for up to $800m in 2018
  • +2 more outcomes

Companies that use SCVC

Customer profile

Named customers17 records

Segments1 record

Ideal customer profiles2 records

SCVC technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

SCVC partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

SCVC competitors and assessment

Company assessment

Direct peers

  • Cambridge Enterprise Ventures: University-linked seed and early-stage investor commercialising University of Cambridge deep tech research. Highly comparable to SCVC in stage, sector focus (biotech, quantum, advanced materials), and UK geography, and has appeared as a SCVC co-investor (e.g., Houdini Bio).
  • Oxford Science Enterprises (OSE): VC firm spun out of Oxford University investing in deep tech and life sciences from university IP. Closely comparable to SCVC in mission (commercialising UK academic deep tech), stage focus, and sector mix.
  • Cambridge Innovation Capital (CIC): Early-stage investor focused on the Cambridge deep tech and life sciences cluster. Closely comparable sector mix (biotech, quantum, AI) and stage, making it a natural UK peer to SCVC.
  • Parkwalk Advisors: UK-based early-stage investor specialising in university spinouts and deep tech from UK research institutions. Directly comparable to SCVC in thesis, stage (pre-seed to Series A), and customer base (technical founders).
  • Deep Science Ventures: Venture builder creating and funding science companies from first principles. Has co-invested with SCVC (e.g., Houdini Bio), and shares a deep tech, science-first thesis with overlapping UK founder pool.
  • Episode 1 Ventures: UK pre-seed and seed investor with meaningful exposure to deep tech and science-led founders. Comparable to SCVC in stage focus and UK orientation, though somewhat broader in sector mandate.

Broad incumbents

  • IP Group: Largest UK-listed IP commercialisation company backing deep tech and life science spinouts from leading universities. Broader and more established than SCVC, but directly comparable in thesis of monetising UK academic deep tech at early stage.
  • Octopus Ventures: One of the largest UK VCs with a dedicated deep tech vertical alongside broader fintech/healthtech investing. More diversified and at larger check sizes, but operates in overlapping UK early-stage deep tech deal flow.
  • LocalGlobe: Prominent UK seed investor with a founder-led approach. While more software/internet biased, it competes with SCVC for top UK technical founders at pre-seed and seed stages.

Regional players

  • Apollo Ventures: European deep tech and biotech-focused early-stage investor. Comparable thesis on deep tech/longevity, though primarily Continental European in focus versus SCVC's UK-centric mandate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

SCVC social profiles

Digital presence

SCVC compliance and trust

Trust signal

Compliance1 record

SCVC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SCVC leadership team

Management profile

Number of profiles

Profiles5 records

SCVC funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SCVC M&A and investment

M&A and investment

M&A

Investments24 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SCVC

What does SCVC do?

SCVC provides early-stage venture capital investment (pre-seed to Series A) into UK-based Deep Tech startups across biotech, quantum, AI, synthetic biology, and advanced materials. The firm applies a proprietary 'technology-product fit' model to guide founders through technical and commercial de-risking, complemented by access to the Science Creates incubator ecosystem, training platform, and development services.

Is SCVC a public or private company?

SCVC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SCVC founded?

SCVC was founded in 2020. It employs 11 to 50 people.

Where is SCVC based?

SCVC is headquartered in Bristol, United Kingdom, in the Europe region.

How does SCVC make money?

One revenue line is on record: venture Capital Returns.

Who are SCVC's main competitors?

Direct peers on record are Cambridge Enterprise Ventures, Oxford Science Enterprises (OSE), Cambridge Innovation Capital (CIC), Parkwalk Advisors, Deep Science Ventures and Episode 1 Ventures. Broad incumbents are IP Group, Octopus Ventures and LocalGlobe. Apollo Ventures is listed as a regional player.

Does SCVC have an API?

No public API is recorded for SCVC.

What industry is SCVC in?

SCVC's product category is Early-Stage Venture Capital (Deep Tech). Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAHAC, Corporate Venture Studios & Incubators (Build/launch ventures). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmagMacclesfield-based Bitrobius Genetics secures £700k from ARIA and SCVCBitrobius Genetics raised £700,000 in pre-seed funding to extend its Gentrafix platform for delivering DNA into mitochondria. The grant from ARIA and SCVC supports a collaboration with the University of Cambridge to explore preclinical delivery for mitochondrial disorders. Success could open therapeutic avenues for conditions like neurodegenerative diseases and cancer.Mirage NewsSheffield Spinout Set to Unlock Next Display TechUniversity of Sheffield spinout Pixel-Flo has raised £5.25 million in funding to develop its MicroLED manufacturing technology, which addresses the mass transfer bottleneck that has prevented large-scale production of next-generation displays for consumer electronics. The funding round was led by Northern Gritstone with participation from SCVC, Parkwalk Northern Universities Venture Fund, and German investment firm HTGF, and will support the company's transition from laboratory development to industrial scale-up.InsidermediaUniversity of Sheffield spin-out raises £5.25m to tackle manufacturing bottleneck - “allows us to expand our team and demonstrate our unique technology”Pixel-Flo, a University of Sheffield spin-out developing fluidic self-assembly technology for microLED display manufacturing, has raised £5.25 million in seed funding led by Northern Gritstone, with participation from SCVC, Parkwalk Northern Universities Venture Fund, and German investment firm HTGF. The funding will support the company's transition from laboratory development to industrial scale-up, including team expansion and relocation to new facilities. Pixel-Flo's technology addresses the scalability bottleneck that has limited mass-market adoption of microLED displays, which offer significantly higher brightness and efficiency than traditional displays.StartupmagGreentech startup Pixel-Flo raises £5.3m led by Northern Gritstone with SCVCPixel-Flo, a University of Sheffield spinout, raised £5.3m in seed funding led by Northern Gritstone and SCVC to industrialize its Continuous-Flow Mass Transfer system for microLED manufacturing. The company aims to address a production bottleneck and lower costs for microLED displays, with plans to expand its team and relocate.BdailyPixel-Flo lights up with £5.25 million raisePixel-Flo, a University of Sheffield spin-out specializing in semiconductor display technology, has raised £5.25 million in an oversubscribed Seed funding round led by Northern Gritstone, with additional participation from SCVC, Parkwalk Northern Universities Venture Fund, and German investor HTGF. The company has developed proprietary Continuous-Flow Mass Transfer technology designed to overcome key manufacturing bottlenecks in MicroLED displays, aiming to reduce production costs while enabling large-scale manufacturing of brighter, more energy-efficient displays for products ranging from smartwatches to televisions. The funding will support Pixel-Flo's transition from laboratory research to industrial scale-up, including team expansion and relocation to larger facilities, as well as demonstrate the technology on a commercial coating system for partnership evaluation with display manufacturing partners.VestbeePixel-Flo raises £5.25M to solve the critical bottleneck in MicroLED manufacturingSheffield-based startup Pixel-Flo has secured £5.25 million in seed funding from Northern Gritstone, SCVC, Parkwalk, and HTGF to develop its microLED display manufacturing technology. The company, founded in 2023, is commercializing Continuous-Flo™, a process that suspends microLED chips in liquid and uses patterned surfaces and fluid forces to position them—offering a faster and more scalable alternative to traditional pick-and-place methods. The funding will support Pixel-Flo's transition from laboratory development to industrial-scale production and enable customer evaluation ahead of commercial deployment.BitlyPixel-Flo lands £5.25M seed round for MicroLED manufacturingPixel-Flo, a University of Sheffield spin-out developing manufacturing technology for MicroLED displays, has raised £5.25 million in seed funding led by Northern Gritstone with participation from SCVC, Parkwalk Northern Universities Venture Fund, and German investment firm HTGF. The company is commercialising a Continuous-Flow Mass Transfer process based on fluidic self-assembly, designed to overcome cost and scalability barriers that have limited broader adoption of MicroLED technology. The funding will support Pixel-Flo's transition from laboratory development to industrial scale-up, including team expansion, new facilities, product development, and international growth.Tech Funding NewsSheffield spinout just raised £5.2M to solve manufacturing problem that has kept MicroLED out of your pocket for a decade — TFNPixel-Flo, a University of Sheffield spinout, raised £5.25 million in seed funding to solve microLED's mass transfer manufacturing bottleneck. Northern Gritstone led the round with participation from SCVC, Parkwalk Northern Universities Venture Fund, and Germany's HTGF. The company plans to use the funding to scale from lab development to industrial production and expand its team, targeting display manufacturers in Asia where most panels are made.VestbeePixel-Flo raises £5.25M to solve the critical bottleneck in MicroLED manufacturingPixel-Flo, a Sheffield-based microLED manufacturing firm, raised £5.25M in seed funding from Northern Gritstone, SCVC, Parkwalk, and HTGF. The company's Continuous-Flo technology suspends microLED chips in liquid for assembly, aiming to scale production. The funding will support transition to industrial-scale production and customer evaluation.SciencecreatesSCVC backs Pixel-Flo's £5m Seed round to commercialise MicroLED manufacturing technologyPixel-Flo, a University of Sheffield spinout, raised £5 million in seed funding to commercialise its Continuous-Flow Mass Transfer technology for MicroLED manufacturing. The round was led by Northern Gritstone with SCVC participation, and the funds will support scale-up and expansion into a new facility.